Science News/The Translational Genomics Research Institute: Sequencing test enables precise identification of drug-resistant TB

Science News

From research organizations

Sequencing test enables precise identification of drug-resistant TB

Researchers advance SMOR testing, with an eye on precision medicine for tuberculosis

Date:
    October 10, 2017
Source:
    The Translational Genomics Research Institute
Summary:
    Two studies document how a new advanced genetic sequencing approach can help thwart the growing worldwide threat posed by drug-resistant mutations of tuberculosis (TB). The threat of TB is increasing in some places as mutant versions of the disease become more and more resistant to current drug treatments.
Share:

FULL STORY

Two studies led by the Translational Genomics Research Institute (TGen) and the University of California San Francisco (UCSF) document how a new advanced genetic sequencing approach can help thwart the growing worldwide threat posed by drug-resistant mutations of tuberculosis (TB).
advertisement

While TB has declined in the U.S. and other developed nations, the infectious lung bacteria remains a major public health threat throughout developing nations, estimated to infect a third of the world's population. The threat of TB is increasing in some places as mutant versions of the disease become more and more resistant to current drug treatments.

"We believe that new targeted sequencing technologies can help physicians provide personalized care for patients with drug-resistant TB," said Dr. David Engelthaler, Co-Director of TGen's Pathogen Genomics Division, and senior author of both studies. "Drug-resistance occurs when the wrong antibiotics are prescribed at the wrong time. This new approach is designed to not only help doctors better treat patients, but to help slow or stop the global threat of multi-drug resistant TB."

One of the TGen-UCSF studies, "Cryptic Micro-heteroresistance Explains M. tuberculosis Phenotypic Resistance," published June 14 in the American Journal of Respiratory and Critical Care Medicine, concludes that using "a targeted next generation sequencing (NGS) approach ... dramatically reduces sequencing error." Such error, inherent in DNA sequencing systems, would otherwise prevent the ability to detect very small, hidden populations of drug-resistant bacteria growing in the lung.

In both studies, the TGen-UCSF team used Single Molecule-Overlapping Reads (SMOR) technology -- invented at TGen -- which precisely identifies variants of TB, even in cases where an older technology, known as Sanger sequencing, found no drug-resistant mutations.
advertisement

A version of this SMOR test is being developed that could be easily deployed to under-developed areas where it may be most needed.

"A user-friendly kit-based version of our assay is currently under development for use with the new desktop DNA Sequencers for rapid drug susceptibility testing in limited resource settings," said Dr. Engelthaler. "It seems counterintuitive to develop cutting edge genomic solutions for problems in our under-developed world, but we are adapting that technology in ways that can be accessible by anyone, nearly anywhere."

Identifying rapidly mutating, drug-resistant strains of TB is the greatest challenge to eradicating this disease, which in 2015 infected 10.4 million and killed 1.8 million people across the globe, according to the U.S. Centers for Disease Control and the World Health Organization -- nearly 5,000 deaths per day worldwide.

"Despite our now global society, it is difficult for many of us to imagine places where an infection, fully curable with antibiotics developed decades ago, can kill more people in their prime than cancer. Unfortunately, due to health systems abroad weakened by neglect and chronic underfunding, highly resistant TB is becoming the 'new normal' TB. Given that we are and have always been a 'melting pot' country and beacon of hope for so many, we will certainly see these cases in the United States," said Dr. John Metcalfe, a pulmonary care specialist and Associate Professor at the UCSF School of Medicine, and the lead author of both TGen-UCSF studies.

The second TGen-UCSF study -- Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance -- published Sept. 11 in the journal Antimicrobial Agents and Chemotherapy, also used "ultra-deep next-generation" SMOR sequencing to examine potentially drug resistant variants of TB.

"This report further documents the previously under-described nature of the drive of the M. tuberculosis organism to mutate and become resistant to our antibiotics," said Dr. Metcalfe, "and further emphasizes the need for additional study of the effects of this phenomenon on both clinical diagnostics and patient outcomes."
advertisement

Story Source:

Materials
provided by The Translational Genomics Research Institute. Note: Content may be edited for style and length.

Journal References:

    John Z Metcalfe, Elizabeth Streicher, Grant Theron, Rebecca E Colman, Christopher Allender, Darrin Lemmer, Rob Warren, David M Engelthaler. Cryptic Micro-heteroresistance Explains M. tuberculosis Phenotypic Resistance. American Journal of Respiratory and Critical Care Medicine, 2017; DOI: 10.1164/rccm.201703-0556OC
    John Z. Metcalfe, Elizabeth Streicher, Grant Theron, Rebecca E. Colman, Renee Penaloza, Christopher Allender, Darrin Lemmer, Robin M. Warren, David M. Engelthaler. Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance. Antimicrobial Agents and Chemotherapy, 2017; AAC.00888-17 DOI: 10.1128/AAC.00888-17

Cite This Page:

    MLA
    APA
    Chicago

The Translational Genomics Research Institute. "Sequencing test enables precise identification of drug-resistant TB: Researchers advance SMOR testing, with an eye on precision medicine for tuberculosis." ScienceDaily. ScienceDaily, 10 October 2017. <www.sciencedaily.com/releases/2017/10/171010133927.htm>.

RELATED STORIES
Drug-Resistant Tuberculosis Set to Increase in Four High Burden Countries
May 9, 2017 — By 2040, a third of tuberculosis cases in Russia are predicted to be drug-resistant, compared with one in ten in India and the Philippines, and one in 20 in South Africa, suggest researchers. The ... read more
Antibiotics Developed in 1960s Show Promise for TB Therapy
Sep. 28, 2016 — First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research. Tuberculosis, ... read more
Imaging Techniques Reliably Predict Treatment Outcomes for TB Patients
Dec. 4, 2014 — Two medical imaging techniques, called positron emission tomography and computed tomography, could be used in combination as a biomarker to predict the effectiveness of antibiotic drug regimens being ... read more
Tackling Multidrug-Resistant, Extensively Drug-Resistant TB: New Consensus Reached
Mar. 24, 2014 — New consensus statements have been developed to help tackle the growing threat of multidrug-resistant tuberculosis (TB) and extensively drug-resistant tuberculosis (TB). The statements mark the first ... read more
FROM AROUND THE WEB
Below are relevant articles that may interest you. ScienceDaily shares links and proceeds with scholarly publications in the TrendMD network.

    Few novel antibiotics in the pipeline, WHO warns
    Zosia Kmietowicz et al., The BMJ, 2017
    Rutgers NJMS, Cepheid Describe 10-Color Assay for Extensively Drug-Resistant TB
    360Dx, 2016
    Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations
    Setiwan J Laksono et al., The BMJ, 2017
    NGS Can Aid in Detecting Drug Resistance in Tuberculosis
    360Dx, 2016

    Drug-Resistant Tuberculosis: Challenges and Progress.
    Sebastian G Kurz et al., Infectious Disease Clinics, 2016
    Corneal Infections—Challenges in Diagnosis and Update on Management
    Bennie H Jeng, US Ophthalmic Rev, 2017
    NIH Grant to Fund Research on Proteomics, Immunoassay for TB Activation in HIV Patients
    360Dx, 2016
    With New Instrument and Assay Claims, BioMérieux Takes on Antibiotic Stewardship
    360Dx, 2017

Powered by TrendMD
Popular Courses
from EdX
Disclosure: ScienceDaily earns commissions from referrals available via the following links.
Minds and Machines
Massachusetts Institute of Technology
What is the relationship between the mind and the body? Can computers think? Do we perceive reality as it is? Can there be a science of consciousness? ... learn more
The Science of Happiness
Berkeley
The first MOOC to teach positive psychology. Learn science-based principles and practices for a happy, meaningful life. ... learn more
Cell Biology: Mitochondria
Harvard University
A human-centered approach to the fundamentals of cell biology with a focus on the power plants of the cell - mitochondria. ... learn more
Greatest Unsolved Mysteries of the Universe
Australian National University
Exploring the biggest mysteries of modern astrophysics. ... learn more
Most Popular
this week
HEALTH & MEDICINE
More Traits Associated With Your Neanderthal DNA
First Evidence of the Body's Waste System in the Human Brain Discovered
Prehistoric Humans Are Likely to Have Formed Mating Networks to Avoid Inbreeding
MIND & BRAIN
Video Gamers Have an Advantage in Learning
'Turbo Charge' for Your Brain?
Why Does Divorce Run in Families? The Answer May Be Genetics
LIVING & WELL
Too Much Sugar? Even 'Healthy People' Are at Risk of Developing Heart Disease
Anxiety and Depression Caused by Childhood Bullying Decline Over Time
The Female Brain Reacts More Strongly to Prosocial Behavior Than the Male Brain, Study Finds
Strange & Offbeat

HEALTH & MEDICINE
A Self-Propelled Catheter With Earthworm-Like Peristaltic Motion
Human Minibrains Reveal Effects of Psychedelic Substance
Smartphone-Controlled Smart Bandage for Better, Faster Healing
MIND & BRAIN
'Turbo Charge' for Your Brain?
More Traits Associated With Your Neanderthal DNA
How Much Can Watching Hockey Stress Your Heart?
LIVING & WELL
Immune System Linked to Alcohol Drinking Behavior
Why Does Rubbing a Balloon on Your Hair Make It Stick?
How a Drug Could Induce Health Benefits of Exercise